At Emergent, we develop, manufacture, and deliver protections against public health threats. For more than two decades, we’ve been at work defending people from things we hope will never happen — so that we’re prepared, just in case they ever do.
Having over-the-counter (OTC) naloxone gives us the opportunity to make it mainstream where it hasn’t been before. The teamwork, hard work, and collaboration that has brought us to this point is essential to me. We have been able to bring this product to OTC because of accessibility, barrier removal, and the opportunity for everyone to have access.
Mari Savickis, VP of Public Policy for CHIME, joins Panda Perspectives live from the VIVE show floor to break down how shifting federal priorities and political uncertainty are impacting digital health progress. As a longtime healthcare policy expert, Mari offers a behind-the-scenes look at how providers are reacting to rapid changes in Washington, highlighting how…
Charlotte Piper, Assistant Vice President of Ochsner Ventures, joins Panda Perspectives to explore how Ochsner Health is leveraging innovation, strategic investment, and deep collaboration to drive real change in healthcare. With a mission to create new value—financial and operational—for the health system, Charlotte shares how her team works across partnerships, internal ventures, and digital transformation…
Sam Shields, System VP of Strategy and Regional Operations at Dartmouth Health, joins Panda Perspectives to discuss how the academic health system is navigating digital transformation in a rural setting. With a recently completed strategic plan, Dartmouth is focused on enhancing care for its aging population through innovative models, AI governance, and robust telehealth infrastructure….